The Trump administration's new health strategy maintains a commitment to global AIDS targets, but experts warn it will undercut the program needed to achieve them.
In a Devex Pro Briefing, professor Lawrence Gostin of the O’Neill Institute for National and Global Health Law and Rachel Bonnifield of the Center for Global Development unpacked the implications of the U.S. State Department's new strategy.
Though polio funding levels have so far remained steady in the United States, several traditional donors — including the United Kingdom and Germany — are expected to make cuts.
There is a growing consensus that global south countries should set their own health priorities, but private sector collaboration will remain critical.
With official development assistance plummeting, governments are under pressure to make up the funds through taxes on tobacco, alcohol, and sugary beverages. But these levies may not be a financial panacea.
An effort led by Ghana's president calls for a paradigm shift toward more equitable global cooperation.
The Trump administration says its future involvement in global health will prioritize country-to-country relationships. The Pan-African public health agency is working to ensure it will play a role in the country’s strategy.
It emphasizes direct relationships and coinvestments with aid-receiving countries, boosting front-line health supplies and workers, protecting Americans from outbreaks originating abroad, and promoting American-made health products.
Health experts have repeatedly pointed to the same structural flaws in global health. But can the sector build a system that is less fragmented, less donor-driven, and more resilient to political shifts?
Experts — including some of the initiatives’ own architects — have varying views. But what’s certain is that it makes for a difficult but timely conversation.
